Nuvation Bio Inc. NUVB

Latest FY: 2025 Healthcare Biotechnology
Market Price $6.76
Market Cap $2.35B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑699.0% YoY
$62.90M
Full year reported
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↓-33.1% YoY
-$173.78M
FCF Yield: -7.38%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (NUVB)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2020 $1.9M $1.9M 0.00% $-0.7M $-0.8M
FY 2021 $-2.7M -241.0% 0.00% $-68.2M $-68.5M -7,995.3%
FY 2022 $-4.3M -58.3% 0.00% $-96.1M $-96.5M -40.9%
FY 2023 +100.0% 0.00% $-68.0M $-68.1M +29.4%
FY 2024 $7.9M $7.5M 0.00% $-130.4M $-130.6M -91.8%
FY 2025 $62.9M +699.0% $49.2M 0.00% $-173.4M $-173.8M -33.1%
$

Valuation

Market Price $6.76
Market Cap $2.35B
Enterprise Value $2.19B
P/E Ratio N/A
P/B Ratio 7.70
FCF Yield -7.38%
Dividend Yield N/A
Shares Outstanding 348,202,000
%

Profitability & Margins

Gross Margin 78.25%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.11x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 1.54
Cash Ratio 21.83
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $164.09M
Total Debt N/A
Book Value / Share $0.88
💧

Cash Flow Efficiency

Operating Cash Flow -$173.43M
Capital Expenditures (CapEx) $354.00K
Free Cash Flow -$173.78M
OCF / Revenue -275.71%
FCF / Revenue -276.27%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $0.88
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $594.82M
Total Liabilities $289.11M
Stockholders' Equity $305.72M
Current Assets $11.54M
Current Liabilities $7.51M